FASTinov announced today an agreement with Beckman Coulter Life Sciences to be an authorized partner for the company’s highly reputable flow cytometry analyzers to clinical microbiology laboratories introducing FASTinov’s ultra-rapid 2h-Antimicrobial Susceptibility Testing.
Read More...This will be a pivotal role in leading the launch of the AST kits in Europe.
Read More...FASTinov technology is discussed in the webinar organized by the Portuguese Society of Clinical Pathology
Read More...The importance of speed in the response to sepsis and the implications of new generation ultra-rapid Susceptibility tests
Read More...
FASTinov will be present at the ECCMID congress in Lisbon, Portugal, on 23-25 April 2022
Read More...The company will progressively introduce its groundbreaking Antibiotic Susceptibility Testing technology...
Read More...
© 2022 FASTinov S.A. - All Rights Reserved - Webdesign by Nova Agência